Stevanović, M

Link to this page

Authority KeyName Variants
orcid::0000-0003-4286-7334
  • Stevanović, M (1)
  • Stevanović, Milena (1)
Projects

Author's Bibliography

Apigenin-7-o-glucoside versus apigenin: insight into the modes of anticandidal and cytotoxic actions

Smiljković, Marija; Stanisavljević, Danijela; Stojković, Dejan; Petrović, Isidora; Marjanović-Vicentić, Jelena; Popović, Jelena; Golic-Grdadolnik, Simona; Marković, Dejan; Sanković-Babić, Snežana; Glamočlija, Jasmina; Stevanović, Milena; Soković, Marina

(Excli Journal Managing Office, Dortmund, 2017)

TY  - JOUR
AU  - Smiljković, Marija
AU  - Stanisavljević, Danijela
AU  - Stojković, Dejan
AU  - Petrović, Isidora
AU  - Marjanović-Vicentić, Jelena
AU  - Popović, Jelena
AU  - Golic-Grdadolnik, Simona
AU  - Marković, Dejan
AU  - Sanković-Babić, Snežana
AU  - Glamočlija, Jasmina
AU  - Stevanović, Milena
AU  - Soković, Marina
PY  - 2017
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/2225
AB  - Bioactive potential of apigenin derivative apigenin-7-O-glucoside related to its antifungal activity on Candida spp. and cytotoxic effect on colon cancer cells was studied and compared with bioactive potential of apigenin. Antifungal activity was tested on 14 different isolates of Candida spp. using membrane permeability assay, measuring inhibition of reactive oxidative species and inhibition of CYP51 C. albicans enzyme. Cytotoxic potential of apigenin- 7-O-glucoside was tested on colon cancer HCT116 cells by measuring cell viability, apoptosis rate and apoptosis- and colon cancer-related gene expression. Obtained results indicated considerable antifungal activity of apigenin-7-O-glucoside towards all Candida isolates. Breakdown of C. albicans plasma membrane was achieved upon treatment with apigenin-7-O-glucoside for shorter period of time then with apigenin. Reduction of intra-and extracellular reactive oxidative species was achieved with minimum inhibitory concentrations of both compounds, suggesting that reactive oxidative species inhibition could be a mechanism of antifungal action. None of the compounds exhibited binding affinity to C. albicans CYP51 protein. Besides, apigenin-7-O-glucoside was more effective compared to apigenin in reduction of cell's viability and induction of cell death of HCT116 cells. Treatment with both compounds resulted in chromatin condensation, apoptotic bodies formation and apoptotic genes expression in HCT116 cells, but the apigenin-7-O-glucoside required a lower concentration to achieve the same effect. Compounds apigenin-7-O-glucoside and apigenin displayed prominent antifungal potential and cytotoxic effect on HCT116 cells. However, our results showed that apigenin-7-O-glucoside has more potent activity compared to apigenin in all assays that we used.
PB  - Excli Journal Managing Office, Dortmund
T2  - EXCLI Journal
T1  - Apigenin-7-o-glucoside versus apigenin: insight into the modes of anticandidal and cytotoxic actions
VL  - 16
SP  - 795
EP  - 807
DO  - 10.17179/excli2017-300
ER  - 
@article{
author = "Smiljković, Marija and Stanisavljević, Danijela and Stojković, Dejan and Petrović, Isidora and Marjanović-Vicentić, Jelena and Popović, Jelena and Golic-Grdadolnik, Simona and Marković, Dejan and Sanković-Babić, Snežana and Glamočlija, Jasmina and Stevanović, Milena and Soković, Marina",
year = "2017",
abstract = "Bioactive potential of apigenin derivative apigenin-7-O-glucoside related to its antifungal activity on Candida spp. and cytotoxic effect on colon cancer cells was studied and compared with bioactive potential of apigenin. Antifungal activity was tested on 14 different isolates of Candida spp. using membrane permeability assay, measuring inhibition of reactive oxidative species and inhibition of CYP51 C. albicans enzyme. Cytotoxic potential of apigenin- 7-O-glucoside was tested on colon cancer HCT116 cells by measuring cell viability, apoptosis rate and apoptosis- and colon cancer-related gene expression. Obtained results indicated considerable antifungal activity of apigenin-7-O-glucoside towards all Candida isolates. Breakdown of C. albicans plasma membrane was achieved upon treatment with apigenin-7-O-glucoside for shorter period of time then with apigenin. Reduction of intra-and extracellular reactive oxidative species was achieved with minimum inhibitory concentrations of both compounds, suggesting that reactive oxidative species inhibition could be a mechanism of antifungal action. None of the compounds exhibited binding affinity to C. albicans CYP51 protein. Besides, apigenin-7-O-glucoside was more effective compared to apigenin in reduction of cell's viability and induction of cell death of HCT116 cells. Treatment with both compounds resulted in chromatin condensation, apoptotic bodies formation and apoptotic genes expression in HCT116 cells, but the apigenin-7-O-glucoside required a lower concentration to achieve the same effect. Compounds apigenin-7-O-glucoside and apigenin displayed prominent antifungal potential and cytotoxic effect on HCT116 cells. However, our results showed that apigenin-7-O-glucoside has more potent activity compared to apigenin in all assays that we used.",
publisher = "Excli Journal Managing Office, Dortmund",
journal = "EXCLI Journal",
title = "Apigenin-7-o-glucoside versus apigenin: insight into the modes of anticandidal and cytotoxic actions",
volume = "16",
pages = "795-807",
doi = "10.17179/excli2017-300"
}
Smiljković, M., Stanisavljević, D., Stojković, D., Petrović, I., Marjanović-Vicentić, J., Popović, J., Golic-Grdadolnik, S., Marković, D., Sanković-Babić, S., Glamočlija, J., Stevanović, M.,& Soković, M.. (2017). Apigenin-7-o-glucoside versus apigenin: insight into the modes of anticandidal and cytotoxic actions. in EXCLI Journal
Excli Journal Managing Office, Dortmund., 16, 795-807.
https://doi.org/10.17179/excli2017-300
Smiljković M, Stanisavljević D, Stojković D, Petrović I, Marjanović-Vicentić J, Popović J, Golic-Grdadolnik S, Marković D, Sanković-Babić S, Glamočlija J, Stevanović M, Soković M. Apigenin-7-o-glucoside versus apigenin: insight into the modes of anticandidal and cytotoxic actions. in EXCLI Journal. 2017;16:795-807.
doi:10.17179/excli2017-300 .
Smiljković, Marija, Stanisavljević, Danijela, Stojković, Dejan, Petrović, Isidora, Marjanović-Vicentić, Jelena, Popović, Jelena, Golic-Grdadolnik, Simona, Marković, Dejan, Sanković-Babić, Snežana, Glamočlija, Jasmina, Stevanović, Milena, Soković, Marina, "Apigenin-7-o-glucoside versus apigenin: insight into the modes of anticandidal and cytotoxic actions" in EXCLI Journal, 16 (2017):795-807,
https://doi.org/10.17179/excli2017-300 . .
66
42
74

Tetraploidy in a 26-month-old girl (cytogenetic and molecular studies)

Guc-Scekić, M; Milašin, Jelena; Stevanović, M; Stojanov, LJ; Đorđević, M

(Wiley, Hoboken, 2002)

TY  - JOUR
AU  - Guc-Scekić, M
AU  - Milašin, Jelena
AU  - Stevanović, M
AU  - Stojanov, LJ
AU  - Đorđević, M
PY  - 2002
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1141
AB  - Liveborn infants with tetraploidy are very rare in human pregnancies and usually die during the first days or months. Seven cases of liveborn infants with tetraploidy have previously been reported. Among them only two 92, XXXX infants survived for longer than 12 months. Here we report on the case of a 26-month-old girl with tetraploidy. The main clinical features of tetraploidy are facial dysmorphism, severely delayed growth and developmental delay. On the basis of molecular studies we discuss the possible origin of the additional chromosome sets in our proband. To our knowledge, this infant is the first reported case of tetraploidy who lived up to 26 months.
PB  - Wiley, Hoboken
T2  - Clinical Genetics
T1  - Tetraploidy in a 26-month-old girl (cytogenetic and molecular studies)
VL  - 61
IS  - 1
SP  - 62
EP  - 65
DO  - 10.1034/j.1399-0004.2002.610112.x
ER  - 
@article{
author = "Guc-Scekić, M and Milašin, Jelena and Stevanović, M and Stojanov, LJ and Đorđević, M",
year = "2002",
abstract = "Liveborn infants with tetraploidy are very rare in human pregnancies and usually die during the first days or months. Seven cases of liveborn infants with tetraploidy have previously been reported. Among them only two 92, XXXX infants survived for longer than 12 months. Here we report on the case of a 26-month-old girl with tetraploidy. The main clinical features of tetraploidy are facial dysmorphism, severely delayed growth and developmental delay. On the basis of molecular studies we discuss the possible origin of the additional chromosome sets in our proband. To our knowledge, this infant is the first reported case of tetraploidy who lived up to 26 months.",
publisher = "Wiley, Hoboken",
journal = "Clinical Genetics",
title = "Tetraploidy in a 26-month-old girl (cytogenetic and molecular studies)",
volume = "61",
number = "1",
pages = "62-65",
doi = "10.1034/j.1399-0004.2002.610112.x"
}
Guc-Scekić, M., Milašin, J., Stevanović, M., Stojanov, L.,& Đorđević, M.. (2002). Tetraploidy in a 26-month-old girl (cytogenetic and molecular studies). in Clinical Genetics
Wiley, Hoboken., 61(1), 62-65.
https://doi.org/10.1034/j.1399-0004.2002.610112.x
Guc-Scekić M, Milašin J, Stevanović M, Stojanov L, Đorđević M. Tetraploidy in a 26-month-old girl (cytogenetic and molecular studies). in Clinical Genetics. 2002;61(1):62-65.
doi:10.1034/j.1399-0004.2002.610112.x .
Guc-Scekić, M, Milašin, Jelena, Stevanović, M, Stojanov, LJ, Đorđević, M, "Tetraploidy in a 26-month-old girl (cytogenetic and molecular studies)" in Clinical Genetics, 61, no. 1 (2002):62-65,
https://doi.org/10.1034/j.1399-0004.2002.610112.x . .
32
20
27